Immunity to Aspergillus in patients with chronic granulomatous disease.
D000293:Adolescent; D000328:Adult; D000908:Antibodies, Fungal / Q000032:analysis; D001228:Aspergillosis / Q000276:immunology / Q000628:therapy; D001230:Aspergillus / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D006105:Granulomatous Disease, Chronic / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007109:Immunity; D007111:Immunity, Cellular; D007158:Immunologic Techniques; D007223:Infant; D008213:Lymphocyte Activation; D010585:Phagocyte Bactericidal Dysfunction / Q000276:immunology*; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use
D000908:Antibodies, Fungal; D014165:Transfer Factor